California CRE News In Your Inbox.
Sign up for Connect emails to stay informed with CRE stories that are 150 words or less.
Intermolecular Renews Full-Building R&D Lease in San Jose
Cushman & Wakefield represented the joint venture ownership of Cannae Partners and equity partner Blue Vista Capital Management in arranging a long-term lease extension for 3011 N. First St., a 146,159-square-foot research and development building in North San Jose. The tenant is Merck affiliate Intermolecular, which has occupied the property for more than a decade.
Todd Beatty, Steve Horton and Kelly Yoder of Cushman & Wakefield represented the landlord. JLL’s Bret Yerkovich and Grant Dettmer represented the tenant. Cannae and Blue Vista have owned 3011 N. First since 2021.
“The building where Intermolecular operates offers a very attractive option as a strategic hub location and its existing infrastructure has proven well-suited to satisfy the tenant’s critical research and development needs,” said Beatty. “It is anticipated that the tenant will also be making additional customized improvements to further upgrade and modernize the facility.”
- ◦Lease


